Douglas P. Chadwick

589 total citations
8 papers, 478 citations indexed

About

Douglas P. Chadwick is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Pathology and Forensic Medicine. According to data from OpenAlex, Douglas P. Chadwick has authored 8 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 3 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Douglas P. Chadwick's work include Chemotherapy-induced cardiotoxicity and mitigation (6 papers), Takotsubo Cardiomyopathy and Associated Phenomena (2 papers) and Cardiac Imaging and Diagnostics (2 papers). Douglas P. Chadwick is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (6 papers), Takotsubo Cardiomyopathy and Associated Phenomena (2 papers) and Cardiac Imaging and Diagnostics (2 papers). Douglas P. Chadwick collaborates with scholars based in United States, Canada and Thailand. Douglas P. Chadwick's co-authors include Eugene H. Herman, Victor J. Ferrans, Steven E. Lipshultz, Nader Rifai, Jun Zhang, Jun Zhang, Kazuyo Takeda, Zu-Xi Yu, Erik Herman and Brian B. Hasinoff and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Toxicology and Applied Pharmacology.

In The Last Decade

Douglas P. Chadwick

8 papers receiving 452 citations

Peers

Countries citing papers authored by Douglas P. Chadwick

Since Specialization

Citations

This map shows the geographic impact of Douglas P. Chadwick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas P. Chadwick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas P. Chadwick more than expected).

Fields of papers citing papers by Douglas P. Chadwick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas P. Chadwick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas P. Chadwick. The network helps show where Douglas P. Chadwick may publish in the future.

Co-authorship network of co-authors of Douglas P. Chadwick

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas P. Chadwick. A scholar is included among the top collaborators of Douglas P. Chadwick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas P. Chadwick. Douglas P. Chadwick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	SK&F 95654-Induced Acute Cardiovascular Toxicity in Sprague-Dawley Rats—Histopathologic, Electron Microscopic, and Immunohistochemical Studies 2002 ·Toxicologic Pathology ·Jun Zhang, Eugene H. Herman, Alan Knapton, Douglas P. Chadwick, (unknown), John Koerner, Thomas Papoian, Victor J. Ferrans, Frank D. Sistare	32
2	The use of serum levels of cardiac troponin T to compare the protective activity of dexrazoxane against doxorubicin- and mitoxantrone-induced cardiotoxicity 2001 ·Cancer Chemotherapy and Pharmacology ·Eugene H. Herman, Jun Zhang, Nader Rifai, Steven E. Lipshultz, Brian B. Hasinoff, Douglas P. Chadwick, Alan Knapton, (unknown), Victor J. Ferrans	86
3	Comparison of the protective effects of amifostine and dexrazoxane against the toxicity of doxorubicin in spontaneously hypertensive rats 2000 ·Cancer Chemotherapy and Pharmacology ·Eugene H. Herman, Jun Zhang, Douglas P. Chadwick, Victor J. Ferrans	98
4	Correlation Between Serum Levels of Cardiac Troponin-T and the Severity of the Chronic Cardiomyopathy Induced by Doxorubicin 1999 ·Journal of Clinical Oncology ·Eugene H. Herman, Jun Zhang, Steven E. Lipshultz, Nader Rifai, Douglas P. Chadwick, Kazuyo Takeda, Zu-Xi Yu, Victor J. Ferrans	169
5	Comparison of the chronic toxicity of piroxantrone, losoxantrone and doxorubicin in spontaneously hypertensive rats 1998 ·Toxicology ·Eugene H. Herman, Jun Zhang, Brian B. Hasinoff, Khanh Tran, Douglas P. Chadwick, John R. Clark, Victor J. Ferrans	6
6	Comparison of the protective effects against chronic doxorubicin cardiotoxicity and the rates of iron (III) displacement reactions of ICRF-187 and other bisdiketopiperazines 1997 ·Cancer Chemotherapy and Pharmacology ·Erik Herman, (unknown), Brian B. Hasinoff, Douglas P. Chadwick, J. Clark, V J Ferrans	23
7	Cardiotoxicity of human recombinant interleukin-2 in rats. A morphological study. 1993 ·Circulation ·John H. Zhang, Zu‐Xi Yu, Stephen L. Hilbert, (unknown), Douglas P. Chadwick, Erik Herman, V J Ferrans	25
8	Modification of some of the toxic effects of daunomycin (NSC-82,151) by pretreatment with the antineoplastic agent ICRF 159 (NSC-129,943) 1974 ·Toxicology and Applied Pharmacology ·Erik Herman, (unknown), Douglas P. Chadwick	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact